HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Source:http://linkedlifedata.com/resource/pubmed/id/18489989

Download in:

View as

General Info

PMID
18489989